Logo
  • Home
  • Our Science
    • Technologies
    • Research
    • Journal Articles
  • Services
  • Who We Are
  • Contact Us
Logo
  • Home
  • Our Science
    • Technologies
    • Research
    • Journal Articles
  • Services
  • Who We Are
  • Contact Us
Our Blog
  • Home
  • Pubblicazioni
  • By admin
  • November 12, 2021

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Galon J, Angell HK, Bedognetti D, Marincola FM.The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity, 2013

Continue Reading
  • By admin
  • November 12, 2021

expression is associated with immune signatures and basal-like phenotype in breast cancer

Insaldi E., Ballestrero A, Bedognetti D, Zoppoli G. Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer. Breast Canc Res and Treat, 2019.

Continue Reading
  • By admin
  • November 12, 2021

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

Bedognetti D, Hendrickx W, Ceccarelli M, Miller LD, Seliger B. Curr Opin Immunol. 2016 Bedognetti D, …Rosenberg SA, Marincola FM. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy

Continue Reading
  • By admin
  • November 12, 2021

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

Rozenblit M…Marincola F, Bedognetti D, Adams S. Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. Scientific Reports, 2019

Continue Reading
  • By admin
  • November 12, 2021

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

Ceccarelli…,Iavarone A, Verhaak R, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, 2016

Continue Reading
  • By admin
  • November 12, 2021

A multi-layer molecular fresco of the immune diversity across hematologic malignancies

Bedognetti D. A multi-layer molecular fresco of the immune diversity across hematologic malignancies. Cancer Cell, September 2020

Continue Reading
  • By admin
  • November 12, 2021

Germline genetic contribution to the immune landscape of cancer

Sayaman R, Saad M, Thorsson V, Wouter Hendrickx, Roelands J, Mokrab Y, Farshidfar F, Kirchhoff T, Sweis RS, Bathe OD, Porta-Pardo E, Campbell MJ, Stretch C, Hu D, Huntsman S,

Continue Reading
  • By admin
  • November 12, 2021

Ligand Significantly Augments Immune Responses to a Dendritic Cell Targeting anti-DEC-205-NY-ESO-1 Vaccine through Expansion of Dendritic Cell Subsets

Bhardwaj N,…Bedognetti et al. Flt3 Ligand Significantly Augments Immune Responses to a Dendritic Cell Targeting anti-DEC-205-NY-ESO-1 Vaccine through Expansion of Dendritic Cell Subsets, Nature Cancer (in press).

Continue Reading
  • By admin
  • November 12, 2021

Prediction of response to anticancer immunotherapy using gene signatures

Wang E, Bedognetti D, Marincola FM. Prediction of response to anticancer immunotherapy using gene signatures. Journal of Clinical Oncology 2013

Continue Reading
  • By admin
  • November 12, 2021

The immune landscape of cancer.

Thorsson V, Gibbs,… Bedognetti D, et al.. The immune landscape of cancer. Immunity, 2018

Continue Reading
  • 1
  • 2
  • »

Search

Category

  • No categories

Archives

Awesome Image
IMMUNOMICA SRL
via Camporeale
83031 ARIANO IRPINO (AV)
P.IVA:03104130640
info@immunomica.com
  • Home
  • Research
  • Publications
  • Who We Are
Powered by Unlimited Technology srl © 2019 All Right Reserved